WHO ICTRP trial
The effect of letrozole supplementation during ovarian stimulation on IVF/ICSI…
ChiCTR2500108624 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500108624 |
|---|---|
| Public title | The effect of letrozole supplementation during ovarian stimulation on IVF/ICSI outcomes in patients with varying ovarian responses |
| Scientific title | The effect of letrozole supplementation during ovarian stimulation on IVF/ICSI outcomes in patients with varying ovarian responses |
| Primary sponsor | SUN YAT-SEN MEMORIAL HOSPITAL |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | Retrospective study |
| Countries | China |
| Conditions | Infertility; Poor ovarian responders; High ovarian responders |
| Interventions | Letrozole Group:None;Control Group:None |
| Registration date | Sep 2, 2025 |
| Target size | Letrozole Group:1000;Control Group:1000 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: